NCT06215976View on ClinicalTrials.gov

The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer

PHASE4RecruitingINTERVENTIONAL

Enrollment

78

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

June 1, 2024

Study Completion Date

December 30, 2024

Conditions

Muscle-Invasive Bladder Carcinoma

Interventions

DRUG

Metformin Hydrochloride 500 MG

Metformin 500mg tablets twice daily

Trial Locations (1)

Unknown

RECRUITING

faculty of pharmacy Cairo university, Cairo

All Listed Sponsors

lead

Cairo University

OTHER